Grant name: Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R21 Clinical Trial Optional)
Funding organization: National Institutes of Health (NIH), National Institute of Mental Health (NIMH)
Total funding amount: $275,000 for a two-year project period
Duration: Maximum of 2 years
Primary objective: To advance innovative research to optimize HIV prevention and care.
Key stakeholders: Researchers, healthcare providers, and communities affected by HIV.
Funding source: Federal government.
Funding type: Grant.
Significance: Addresses critical barriers in HIV prevention and care.
Grant frequency: Recurring.
Higher Education Institutions
Public/State Controlled Institutions of Higher Education
Private Institutions of Higher Education
Nonprofits (with and without 501(c)(3) status)
For-Profit Organizations (including Small Businesses)
Local, State, County, City Governments
Indian/Native American Tribal Governments (both Federally Recognized and not)
Federal Agencies
U.S. Territories
Other entities such as Independent School Districts, Public Housing Authorities, Faith-based Organizations, and Foreign Institutions.
Organizations must complete registrations with SAM, eRA Commons, and Grants.gov.
All PDs/PIs must have an eRA Commons account.
Research on HIV prevention and care continuum.
Innovative intervention approaches.
Behavioral and social science studies.
Individuals living with HIV.
High-incidence populations.
Research teams are encouraged to include community members and relevant organizations.
Multidisciplinary approaches are recommended.
Combined budget for direct costs may not exceed $275,000.
No more than $200,000 may be requested in any single year.
Open Date: April 09, 2023.
Application deadlines vary, with the latest being January 09, 2026.
Must adhere to NIH policies and guidelines.
Involvement of human subjects must comply with ethical standards.
Applications must follow the SF424 (R&R) Application Guide.
Data Management and Sharing Plan is required.